• FR
  • EN
  • JP
  • News
  • Careers
  • Contact Us
Menu

Oncodesign innovation vector.

Oncodesign
  • About
  • Offerings
  • Innovation model
  • Technologies
  • Investors
 

News

  • News
  • Upcoming events
  • Webinars
  • Scientific publications
    • Papers
      • Papers 2012-2017
      • Papers 2006-2011
      • Papers 2002-2005
      • Papers 1999-2001
      • Papers 1995-1998
      • Papers 1988-1994
    • Posters
      • Posters & Presentations 2020
      • Posters & Presentations 2019
      • Posters & Presentations 2018
      • Posters 2017
      • Posters 2016
      • Posters 2015
      • Posters 2014
      • Posters 2013
      • Posters 2012
      • Posters 2011
      • Posters 2010
      • Posters 2009
      • Posters 2008
      • Posters 2007
      • Posters 2006
      • Posters 2004-2005
      • Posters 2000-2003
  1. Home
  2. News
  3. [Congress] Microbiome & Probiotics R&D & Business Collaboration Forum: Europe, November 30 – December 1

Tweets by OncodesignSA

[Congress] Microbiome & Probiotics R&D & Business Collaboration Forum: Europe, November 30 – December 1

[Congress] Microbiome & Probiotics R&D & Business Collaboration Forum: Europe, November 30 – December 1

We offer tailor-made strategies to study the vitro/vivo efficacy of your bacterial-based treatments and/or the effect of your therapies on the microbiota. 

Join Dr Sylvie Maubant during the "speed networking" sessions and discover the scientific expertise of Oncodesign implemented to evaluate the interaction between the tumour, the microbiota and the therapies.

We will be connected to give you the answers you need for your project.

This email address is being protected from spambots. You need JavaScript enabled to view it.

I want to know more!

About Oncodesign
  • Vision
  • Our mission
  • Key figures
  • Management
  • Scientific Advisory Board
  • Where to find us
Offerings
  • Services
  • Partnerships 
  • Licensing
  • Therapeutic areas & Experimental models
Our innovation model
  • Etiology
  • Discovery
  • Experimentation
Our technologies
  • Nanocyclix®
  • T.O.T.
  • PREDICT®
  • Chi-mice®
  • Pharmimage®
  • OncoSNIPE®
Investors
  • A word from the Chairman
  • Financial calendar
  • Shares
  • Documentation
  • Sign up for email alerts
  • Investors contacts
Carreers
  • Our values
  • Job offers/work-study arrangements
  • Internships
  • Spontaneous applications
News
  • Upcoming events
  • Webinars
  • Scientific publications
Contact
  • Contact us
  • Sales team
logo AFSII
logo AAALAC

Personal Data PolicyLegal noticeContact Us

(C) copyright Oncodesign - all right reserved

20 rue Jean Mazen | B.P. 27627 | 21076 Dijon Cedex | France | Tel.+33 (0)3.80.78.82.60 | Fax +33 (0)3.80.78.82.61

Newsletter- en

Subscribe to the general newsletter

Invalid Input

Invalid Input

Invalid Input

Subscribe to the Investor Alert

Oncodesign